DoW Pancreatic Cancer Research Program, Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $9.9M
- Closes
- Oct 7, 2026 (in 20 days)
Similar opportunities open now
- DoW Pancreatic Cancer Research Program, Focused Pilot AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 20 days
- DoW Pancreatic Cancer Research Program, Translational Research Partnership AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 20 days
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW Peer Reviewed Cancer, Idea AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 18 days
- DoW Autism Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 35 days
Classification and identifiers
- Solicitation number
- HT942526PCARPIDA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $9.9M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism supports innovative ideas with the potential to yield impactful data and new avenues of investigation. All applications must address at least one of the FY26 PCARP Focus Areas . Distinctive Features: This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Partnering Principal Investigator (PI) Option for Early-Career...